What is an orphan drug?

Orphan Drugs: Ensuring Access to Treatment for Rare Diseases

An orphan drug is a treatment prescribed to patients affected by a rare disease. A specific regulation was introduced by the European Union to encourage pharmaceutical and biotechnology companies to develop such medicines, ensuring that patients suffering from rare conditions can benefit from high-quality treatments.

Rare Diseases

A rare disease affects fewer than 30,000 people. As a result, the development and commercialization of an orphan drug cannot usually be financially sustained by sales alone. In this context, it is challenging for pharmaceutical companies to invest in treatments aimed at diagnosing, preventing, or treating rare diseases under standard market conditions.

However, it is universally recognized that patients affected by rare diseases must have access to treatments of the same quality as those available for more common conditions. This is why regulatory authorities have decided to encourage the pharmaceutical industry to research, develop, and market therapies specifically designed for rare diseases.

At Unither Pharmaceuticals, we manufacture and package commercial batches of orphan drugs, supporting our partners throughout the pharmaceutical lifecycle.

Expertise in Orphan Drug Manufacturing

Thanks to a broad range of products and expertise combining innovation and development, we design pharmaceutical dosage forms adapted to a wide variety of treatments. This know-how allows us to develop formulations specifically targeting rare diseases.

Our experience in orphan drug manufacturing is a guarantee of quality, safety, and regulatory compliance.

Access to Treatment for All Patients

It is inconceivable that patients suffering from rare diseases should be unable to access treatments adapted to their conditions. They are entitled to the same level of care as any other patient.

Several public initiatives and regulatory measures encourage pharmaceutical and biotechnology companies to continue their efforts in orphan drug research and development. Unither Pharmaceuticals’ primary mission is to develop innovative, sustainable, and competitive treatments tailored to patient needs, enabling our pharmaceutical partners to bring them to market.

Our objective is to offer healthcare products that are accessible to all and easy to use, in order to improve the daily lives of patients affected by rare diseases worldwide.